APOE and fatty liver disease: Genetic factors, such as APOE and others [65], are synergistic with metabolic-associated fatty liver disease, medications [43,46,51,55,56], and environmentally sustained and seemingly harmless nanoparticles, i.e., the case of silica, magnificently illustrated in the work of Abulikemu et al. [45].